These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1379391)

  • 1. Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Chong P; Tripet B; Brush B; Gillam S
    Virology; 1992 Aug; 189(2):483-92. PubMed ID: 1379391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody.
    Trudel M; Nadon F; Séguin C; Amarouch A; Payment P; Gillam S
    J Virol Methods; 1985 Dec; 12(3-4):243-50. PubMed ID: 2422194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.
    Wolinsky JS; Sukholutsky E; Moore WT; Lovett A; McCarthy M; Adame B
    J Virol; 1993 Feb; 67(2):961-8. PubMed ID: 7678312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody-defined epitope map of expressed rubella virus protein domains.
    Wolinsky JS; McCarthy M; Allen-Cannady O; Moore WT; Jin R; Cao SN; Lovett A; Simmons D
    J Virol; 1991 Aug; 65(8):3986-94. PubMed ID: 1712855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing monoclonal antibody to the E1 glycoprotein epitope of rubella virus mediates virus arrest in VERO cells.
    Cordoba P; Grutadauria S; Cuffini C; Zapata M
    Viral Immunol; 2000; 13(1):83-92. PubMed ID: 10733171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies directed to E1 glycoprotein of rubella virus.
    Umino Y; Sato TA; Katow S; Matsuno T; Sugiura A
    Arch Virol; 1985; 83(1-2):33-42. PubMed ID: 2578781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping T-cell epitopes of rubella virus structural proteins E1, E2, and C recognized by T-cell lines and clones derived from infected and immunized populations.
    Ou D; Chong P; Tingle AJ; Gillam S
    J Med Virol; 1993 Jul; 40(3):175-83. PubMed ID: 7689090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the rubella E1 epitopes.
    Terry GM; Ho-Terry L; Londesborough P; Rees KR
    Arch Virol; 1988; 98(3-4):189-97. PubMed ID: 2450528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.
    McCarthy M; Lovett A; Kerman RH; Overstreet A; Wolinsky JS
    J Virol; 1993 Feb; 67(2):673-81. PubMed ID: 7678302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of three minimal T helper cell epitopes of rubella virus E1 glycoprotein.
    Marttila J; Ilonen J; Lehtinen M; Parkkonen P; Salmi A
    Clin Exp Immunol; 1996 Jun; 104(3):394-7. PubMed ID: 9099921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity.
    Giessauf A; Letschka T; Walder G; Dierich MP; Würzner R
    J Immunol Methods; 2004 Apr; 287(1-2):1-11. PubMed ID: 15099751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia.
    van Rijn PA; van Gennip HG; de Meijer EJ; Moormann RJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2053-60. PubMed ID: 7691986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Ou D; Chong P; Gillam S
    J Clin Immunol; 1993 Mar; 13(2):93-100. PubMed ID: 8320313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R237 and h238 are key amino acids in the rubella virus E1 neutralization epitope.
    Li ZM; Chu FL; Wen HL; Sun ZH; Li GH; Xie WY; Wang ZY
    Viral Immunol; 2014 Nov; 27(9):422-9. PubMed ID: 25226223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immunoreactive regions of rubella virus E1 and E2 envelope proteins by using synthetic peptides.
    Mitchell LA; Décarie D; Tingle AJ; Zrein M; Lacroix M
    Virus Res; 1993 Jul; 29(1):33-57. PubMed ID: 7692685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of synthetic peptides with sequences of rubella virus E1 polypeptide by antibodies and T lymphocytes.
    Ilonen J; Seppänen H; Närvänen A; Korkolainen M; Salmi AA
    Viral Immunol; 1992; 5(3):221-8. PubMed ID: 1384533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence variation and biological activity of rubella virus isolates.
    Londesborough P; Ho-Terry L; Terry G
    Arch Virol; 1995; 140(3):563-70. PubMed ID: 7537491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.
    Green KY; Dorsett PH
    J Virol; 1986 Mar; 57(3):893-8. PubMed ID: 2419590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein. Influence of HLA-DR4 polymorphism on T-cell clonal recognition.
    Ou D; Mitchell LA; Ho M; Dćarie D; Tingle AJ; Nepom GT; Lacroix M; Zrein M
    Hum Immunol; 1994 Mar; 39(3):177-87. PubMed ID: 7517931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.
    Qiu Z; Tufaro F; Gillam S
    Virology; 1992 Oct; 190(2):876-81. PubMed ID: 1381541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.